News

The Globe and Mail
theglobeandmail. com > investing > markets > stocks > ABBV-N > pressreleases > 1961425 > abbvie-quietly-expands-its-obesity-bet-with-new-abbv-295-trial

Abb Vie Quietly Expands Its Obesity Bet With New ABBV-295 Trial

5+ hour, 13+ min ago  (270+ words) Abbvie (ABBV) announced an update on their ongoing clinical study. The trial tests ABBV-295, a subcutaneous injection designed to help adults with obesity lose weight and tolerate long term treatment. Participants receive either ABBV-295 or a placebo, allowing researchers to…...

The Globe and Mail
theglobeandmail. com > life > article-ultraprocessed-foods-diet-reader-submissions

Globe readers share how they're avoiding ultraprocessed foods in their daily lives

8+ hour, 53+ min ago  (464+ words) We asked Globe readers to share their tips on how they've been trying to cut out UPFs from their diet, and how they make it work for their varied lifestyles. From meal prepping models to handy kitchen gadgets, here's what…...

The Globe and Mail
theglobeandmail. com > investing > markets > stocks > ABBV-N > pressreleases > 1961447 > abbvies-abbv-951-parkinsons-extension-study-completes-setting-up-key-long-term-safety-readout

Abb Vie's ABBV-951 Parkinson's Extension Study Completes, Setting Up Key Long-Term Safety Readout

5+ hour, 13+ min ago  (218+ words) Abbvie (ABBV) announced an update on their ongoing clinical study. The treatment under review is ABBV-951, a continuous under-the-skin infusion that delivers a combination of foslevodopa and foscarbidopa, prodrugs of standard Parkinson's medicine. Its goal is to smooth out motor…...

The Globe and Mail
theglobeandmail. com > investing > markets > stocks > LLY-N > pressreleases > 1961423 > lilly-extends-als-pipeline-with-new-long-term-safety-trial-for-ly4256984

Lilly Extends ALS Pipeline With New Long-Term Safety Trial for LY4256984

5+ hour, 13+ min ago  (152+ words) Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The treatment being tested is LY4256984, an experimental drug delivered directly into the spinal fluid. The aim is to see whether repeated dosing remains safe and manageable over…...

The Globe and Mail
theglobeandmail. com > investing > markets > markets-news > Newswire. ca > 1958513 > cjf-announces-2026-indigenous-health-journalism-fellow

CJF Announces 2026 Indigenous Health Journalism Fellow

8+ hour, 1+ min ago  (53+ words) The Globe and Mail CJF Announces 2026 Indigenous Health Journalism Fellow TORONTO, May 15, 2026 /CNW/ - The Canadian Journalism Foundation (CJF) is proud to announce that Karyn Pugliese is the recipient of this year's CJF Indigenous Health Journalism Fellowship in partnership with the…...

The Globe and Mail
theglobeandmail. com > world > article-new-ebola-outbreak-remote-congo-province-ituri

New Ebola outbreak in remote Congo province kills 65

9+ hour, 20+ min ago  (634+ words) Thermometers are pictured at the entrance of an Ebola Treatment Centre in the Eastern Congolese town of Butembo in the Democratic Republic of Congo, in October, 2019. Zohra Bensemra/Reuters Africa's top public health body on Friday confirmed a new Ebola…...

The Globe and Mail
theglobeandmail. com > opinion > article-opioid-overdoses-organ-donation-memoir

Opinion: When opioids kill some of us and bring organs to others, that is not a mixed blessing

11+ hour, 53+ min ago  (265+ words) When opioids kill some of us, and their organs go to others, no one should see that as a mixed blessing " we should question the system, and who benefits most Arizona O'Neill is a Montreal author and artist, and one…...

The Globe and Mail
theglobeandmail. com > investing > globe-advisor > advisor-news > article-addressing-cognitive-issues-with-aging-clients-is-a-touchy-subject

Addressing cognitive issues with aging clients is a touchy subject. Here's where to start

16+ hour, 23+ min ago  (1219+ words) Neela White was well-versed in all the issues related to aging. With a degree in gerontology and experience working in long-term care, she was familiar with the system and the diseases that come with growing old. But it was only…...

The Globe and Mail
theglobeandmail. com > investing > markets > markets-news > Newsfile > 1944696 > eesystemtm-inventor-dr-sandra-rose-michael-launches-a-five-city-tour-across-ohio-michigan-and-illinois

EESystem(TM) Inventor Dr. Sandra Rose Michael Launches a Five-City Tour Across Ohio, Michigan, and Illinois

22+ hour, 52+ min ago  (686+ words) Five EESystem(TM) Centers -- Way to Go Wellness, Urban Retreat Ministry, Heaven On Earth Well-Being Center, Quantum Waves Wellness, and Energy Light Center -- Welcome Dr. Sandra Rose Michael for a Historic Week of Healing Events Figure 1- EESystem Logo "We are…...

Google News
theglobeandmail. com > investing > markets > stocks > ISRG > pressreleases > 1938036 > rvty-expands-endocrine-diagnostics-with-fda-cleared-testosterone-assay

RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay

1+ day, 4+ hour ago  (388+ words) Following the announcement, RVTY shares dropped 4. 3% at yesterday's closing. In the year-to-date period, shares of the company lost 1. 8% compared with the industry's 10. 3% decline. However, the S&P 500 has risen 8. 7% in the same timeframe. RVTY currently has a market capitalization of…...